Does SARGRAMOSTIM Cause Off label use? 98 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 98 reports of Off label use have been filed in association with SARGRAMOSTIM (Leukine). This represents 16.5% of all adverse event reports for SARGRAMOSTIM.
98
Reports of Off label use with SARGRAMOSTIM
16.5%
of all SARGRAMOSTIM reports
12
Deaths
10
Hospitalizations
How Dangerous Is Off label use From SARGRAMOSTIM?
Of the 98 reports, 12 (12.2%) resulted in death, 10 (10.2%) required hospitalization, and 2 (2.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SARGRAMOSTIM. However, 98 reports have been filed with the FAERS database.
What Other Side Effects Does SARGRAMOSTIM Cause?
Pyrexia (76)
Pain (56)
Hospitalisation (31)
Death (30)
Hypotension (25)
Device related infection (23)
Cough (20)
Febrile neutropenia (20)
Disease progression (18)
Device related bacteraemia (17)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which SARGRAMOSTIM Alternatives Have Lower Off label use Risk?
SARGRAMOSTIM vs SARILUMAB
SARGRAMOSTIM vs SATRALIZUMAB
SARGRAMOSTIM vs SATRALIZUMAB-MWGE
SARGRAMOSTIM vs SAXAGLIPTIN
SARGRAMOSTIM vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER